Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CEDIA Heroin Metabolite (6-AM) Assay

K-Number: K231007 · 2023-09-27

Decision Date2023-09-27
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

CEDIA Heroin Metabolite (6-AM) Assay is a medical device manufactured by Microgenics Corporation. It received FDA 510(k) clearance on 2023-09-27 under approval number K231007. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CEDIA Heroin Metabolite (6-AM) Assay?

CEDIA Heroin Metabolite (6-AM) Assay is a medical device that received FDA 510(k) clearance on 2023-09-27. It is manufactured by Microgenics Corporation. The 510(k) number is K231007.

When was CEDIA Heroin Metabolite (6-AM) Assay approved by the FDA?

CEDIA Heroin Metabolite (6-AM) Assay received FDA 510(k) clearance on 2023-09-27, under approval number K231007.

What company makes CEDIA Heroin Metabolite (6-AM) Assay?

CEDIA Heroin Metabolite (6-AM) Assay is manufactured by Microgenics Corporation.

What is the FDA product code for CEDIA Heroin Metabolite (6-AM) Assay?

The FDA product code for CEDIA Heroin Metabolite (6-AM) Assay is DJG.

Other Devices by Microgenics Corporation

View all 14 devices →

Related Devices (Code: DJG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.